Galea MH - Search Results

1

Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.

Galea MH, Athanassiou E, Bell J, Dilks B, Robertson JF, Elston CW, Blamey RW, Ellis IO. Galea MH, et al. J Pathol. 1991 Nov;165(3):221-7. doi: 10.1002/path.1711650305. J Pathol. 1991. PMID: 1722247

2

The Nottingham Prognostic Index in primary breast cancer.

Galea MH, Blamey RW, Elston CE, Ellis IO. Galea MH, et al. Breast Cancer Res Treat. 1992;22(3):207-19. doi: 10.1007/BF01840834. Breast Cancer Res Treat. 1992. PMID: 1391987

3

Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells.

O'Donoghue AE, Poller DN, Bell JA, Galea MH, Elston CW, Blamey RW, Ellis IO. O'Donoghue AE, et al. Among authors: galea mh. Breast Cancer Res Treat. 1995;33(2):137-45. doi: 10.1007/BF00682721. Breast Cancer Res Treat. 1995. PMID: 7749141

4

Local recurrence after simple mastectomy.

O'Rourke S, Galea MH, Morgan D, Euhus D, Pinder S, Ellis IO, Elston CW, Blamey RW. O'Rourke S, et al. Among authors: galea mh. Br J Surg. 1994 Mar;81(3):386-9. doi: 10.1002/bjs.1800810321. Br J Surg. 1994. PMID: 8173907

5

Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma.

Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, Robertson JF, Ellis IO. Pereira H, et al. Among authors: galea mh. Histopathology. 1995 Sep;27(3):219-26. doi: 10.1111/j.1365-2559.1995.tb00213.x. Histopathology. 1995. PMID: 8522285

6

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.

Poller DN, Hutchings CE, Galea M, Bell JA, Nicholson RA, Elston CW, Blamey RW, Ellis IO. Poller DN, et al. Br J Cancer. 1992 Sep;66(3):583-8. doi: 10.1038/bjc.1992.318. Br J Cancer. 1992. PMID: 1355662 Free PMC article.

7

Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up.

Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Ellis IO, et al. Histopathology. 1992 Jun;20(6):479-89. doi: 10.1111/j.1365-2559.1992.tb01032.x. Histopathology. 1992. PMID: 1607149

8

Metallothionein expression in human breast cancer.

Goulding H, Jasani B, Pereira H, Reid A, Galea M, Bell JA, Elston CW, Robertson JF, Blamey RW, Nicholson RA, et al. Goulding H, et al. Br J Cancer. 1995 Oct;72(4):968-72. doi: 10.1038/bjc.1995.443. Br J Cancer. 1995. PMID: 7547250 Free PMC article.

9

An evaluation of the cell cycle-associated monoclonal antibody Ki-S1 as a prognostic factor in primary invasive adenocarcinoma of the breast.

Morris ES, Elston CW, Bell JA, Galea M, Blamey RW, Ellis IO. Morris ES, et al. J Pathol. 1995 May;176(1):55-62. doi: 10.1002/path.1711760109. J Pathol. 1995. PMID: 7616357

10

Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.

Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blamey RW, Ellis IO. Poller DN, et al. Mod Pathol. 1994 Feb;7(2):257-62. Mod Pathol. 1994. PMID: 7911998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters